A further application of the nitroblue tetrazolium test.
The nitroblue tetrazolium (N.B.T.) test was performed on patients in whom a differential diagnosis of pulmonary thromboembolism or lobar pneumonia existed. The mean N.B.T. score in healthy subjects was 6.4% (range 1%-15%). Patients with uncomplicated pulmonary thromboembolism showed a mean N.B.T. value of 7.5% (range 3%-12%). In patients with lobar pneumonia the mean N.B.T. score was 42.4% (range 21%-85%). These results suggest that the N.B.T. test is of value in the differential diagnosis of pulmonary thromboembolism and lobar pneumonia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000792:Angiography; D003937:Diagnosis, Differential; D005260:Female; D006321:Heart / Q000503:physiopathology; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D011018:Pneumonia, Pneumococcal / Q000097:blood / Q000175:diagnosis* / Q000503:physiopathology; D011655:Pulmonary Embolism / Q000097:blood / Q000175:diagnosis* / Q000503:physiopathology; D013778:Tetrazolium Salts
D013778:Tetrazolium Salts